Marta
Llanos Muñoz
Profesora Asociada Asistencial
![Foto de Marta](/img/nophoto.png)
![Foto de Hospital Regional Universitario de Málaga](/img/noimage_org.png)
Hospital Regional Universitario de Málaga
Málaga, EspañaPublicaciones en colaboración con investigadores/as de Hospital Regional Universitario de Málaga (7)
2021
-
First-Line Biological Agents Plus Chemotherapy in Older Patients with Metastatic Colorectal Cancer: A Retrospective Pooled Analysis
Drugs and Aging, Vol. 38, Núm. 3, pp. 219-231
2012
-
First-Line XELOX plus bevacizumab followed by XELOX plus bevacizumab or single-agent bevacizumab as maintenance therapy in patients with metastatic colorectal cancer: The phase III MACRO TTD study
Onkologie, Vol. 6, Núm. 2, pp. 96-103
-
First-line XELOX plus bevacizumab followed by XELOX plus bevacizumab or single-agent bevacizumab as maintenance therapy in patients with metastatic colorectal cancer: The phase III MACRO TTD study
Oncologist, Vol. 17, Núm. 1, pp. 15-25
-
Role of Kras Status in Patients with Metastatic Colorectal Cancer Receiving First-Line Chemotherapy plus Bevacizumab: A TTD Group Cooperative Study
PLoS ONE, Vol. 7, Núm. 10
2008
-
R-CHOP-14 in patients with diffuse large B-cell lymphoma younger than 70 years: A multicentre, prospective study
Hematological Oncology, Vol. 26, Núm. 1, pp. 27-32
2004
-
Treatment of stage I and II Hodgkin's lymphoma with ABVD chemotherapy: Results after 7 years of a prospective study
Annals of Oncology, Vol. 15, Núm. 12, pp. 1798-1804
2003
-
Sequential doxorubicin and docetaxel as first-line treatment in metastatic breast cancer: A GEICAM-9801 phase II study
Breast Cancer Research and Treatment, Vol. 77, Núm. 1, pp. 1-8